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Problem Definition
Background: Cardiovascular disease (CVD) remains the 
leading cause of death in the United States, responsible for 
840,768 deaths in 2016.. In addition to previously well 
described atherosclerotic risk factors (advancing age, male 
gender, hypertension, dyslipidemias, diabetes, cigarette 
smoking and family history), an underrecognized surrogate 
marker for CAD is coronary artery calcification (CAC). This 
should be considered diagnostic for CAD. In the PROVIDI 
study, using a qualitative scoring system for CAC, the authors 
found a stepwise increase in the likelihood of cardiovascular 
events with increasing CAC burden (four-fold increase in CV 
events in patients with severe CAC relative to patients without 
CAC). Yet despite this, CAC remains an under-recognized and 
under-reported marker of CAD and an opportunity for 
improvement. 
Study population: For this project, we have selected a total 
of 194 patients aged ≥40 years who had an inpatient stay at 
TJUH between July of 2018 and June of 2019, did not have an 
existing diagnosis of CAD and had CT imaging of the chest for 
any indication. Results: There was a higher prevalence of 
females in this study 57% compared to males 43%. The 
majority of the patients fell into the age range of 60-79 and 
were White. Among the patients with CAC on CT, 57% were not 
taking a statin. Among the patients with diagnosis of diabetes 
and CAC on CT, 33% were not taking a statin. 31% of patients 
with hyperlipidemia and CAD findings were not taking a statin. 
Among those who had severe CAC, 30% were not prescribed a 
statin. Among them only 1 patient (2%) was prescribed 
alternative cholesterol lowering medication (ezetimibe).  Only 
18% of patients who had CAC had CAD discussed in their 
chart. 31% of patients who had evidence of CAD on CT had 
follow-up with cardiology. 48% of patients with CAC on CT had 
Jefferson providers as PCP. Among them, 51% had follow-up 
with PCP shortly after imaging and only 11% had CAD 
discussed during that visit. 
Overall aim: Improve diagnosis and management of CAD 
based on CT chest imaging.
• Improve diagnosis of silent CAD based on CT chest imaging: 
more patients who have findings of CAC on CT chest 
imaging will be diagnosed with CAD.
• Increase the number of appropriate statin prescriptions 
based on CAD findings on CT chest imaging. 
Proposed Intervention Measurement Strategy
The following will serve as our outcome, process and balancing 
measures:
Implementation Plan
Our proposed intervention has three components which will be 
implemented sequentially. 
• First, we are working with the radiology department to have 
a standardized reporting system for CAC by creating a 
dictation template. 
• The second portion of our intervention would be inclusion 
of CT findings in the best practice advisory section in Epic. 
This will alert any provider accessing the patient's chart that 
the patient does have CAC on CT. If a patient does have CAC 
and is not already prescribed a statin, the best practice 
advisory will highlight this discrepancy. 
• The final portion of our proposed intervention will prompt 
the PCP to have a discussion about the presence of CAD and 
risks and benefits of statin initiation. Before this can be 
implemented, we will plan to have an educational campaign 
with primary care providers on this change in reporting and 
recommendations. 
Fig 1. Summary of important findings based on initial analysis of study 
population. 
Our overall goal is to bring incidental CAC findings to the 
attention of primary care physicians with the hope of 
increasing recognition of this surrogate marker of CAD and 
increasing statin use in this population.
1. Standardize the reporting format for CAC on CT chest. 
2. Creation of best practice advisory for CAC CT findings in 
Epic. 
3. Educate Jefferson primary care providers on new best 
practice advisory that will prompt them to have a 
discussion about the presence of CAD and risks and 
benefits of statin initiation. 
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Fig 2. Percent of patients with CAC findings on CT who had an internal 
PCP, followed-up with their PCP shortly after imaging and had CAD 
discussed by PCP during that visit. 
Aims For Improvement
